10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Legal and regulatory responses to innovative treatment.

      1
      Medical law review

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Developments in medical technology, healthcare delivery, and commercial interests in medicine have increased both the potential for conflicts of interest on the part of physicians, and doubts over the sufficiency of patient autonomy as a justification for administering innovative therapy. The legal and regulatory treatment of innovative therapy is therefore an important question, on which there is a current lack of consensus on a number of issues. This paper discusses recent developments in Singapore and uses them as a springboard to flesh out basic regulatory issues that arise from the deployment of innovative treatment: the distinction between innovative treatment and clinical research, the adequacy of the current post hoc scrutiny of innovative therapy under existing legal principles and the need for further specialised regulatory oversight.

          Related collections

          Author and article information

          Journal
          Med Law Rev
          Medical law review
          1464-3790
          0967-0742
          2013
          : 21
          : 1
          Affiliations
          [1 ] Faculty of Law, National University of Singapore. lawchant@nus.edu.sg
          Article
          fws025
          10.1093/medlaw/fws025
          23059815
          7e5abc0a-f061-4aaf-81ac-ae43cf7481e8
          History

          Comments

          Comment on this article